Version 1
: Received: 23 July 2024 / Approved: 24 July 2024 / Online: 24 July 2024 (11:40:53 CEST)
How to cite:
Ciumarnean, L.; Sârb, O. F.; Draghici, N. C.; Salagean, O.; Milaciu, M. V.; Orasan, O. H.; Vlad, C. V.; Vlad, I. M.; Alexescu, T.; Para, I.; Tarmure, S.; Hiriscau, I.-E.; Dogaru, G. B. Obesity Control and Nutraceuticals in the Aid of Brain Plasticity in Multiple Sclerosis Patients. Preprints2024, 2024071943. https://doi.org/10.20944/preprints202407.1943.v1
Ciumarnean, L.; Sârb, O. F.; Draghici, N. C.; Salagean, O.; Milaciu, M. V.; Orasan, O. H.; Vlad, C. V.; Vlad, I. M.; Alexescu, T.; Para, I.; Tarmure, S.; Hiriscau, I.-E.; Dogaru, G. B. Obesity Control and Nutraceuticals in the Aid of Brain Plasticity in Multiple Sclerosis Patients. Preprints 2024, 2024071943. https://doi.org/10.20944/preprints202407.1943.v1
Ciumarnean, L.; Sârb, O. F.; Draghici, N. C.; Salagean, O.; Milaciu, M. V.; Orasan, O. H.; Vlad, C. V.; Vlad, I. M.; Alexescu, T.; Para, I.; Tarmure, S.; Hiriscau, I.-E.; Dogaru, G. B. Obesity Control and Nutraceuticals in the Aid of Brain Plasticity in Multiple Sclerosis Patients. Preprints2024, 2024071943. https://doi.org/10.20944/preprints202407.1943.v1
APA Style
Ciumarnean, L., Sârb, O. F., Draghici, N. C., Salagean, O., Milaciu, M. V., Orasan, O. H., Vlad, C. V., Vlad, I. M., Alexescu, T., Para, I., Tarmure, S., Hiriscau, I. E., & Dogaru, G. B. (2024). Obesity Control and Nutraceuticals in the Aid of Brain Plasticity in Multiple Sclerosis Patients. Preprints. https://doi.org/10.20944/preprints202407.1943.v1
Chicago/Turabian Style
Ciumarnean, L., Ioana-Elisabeta Hiriscau and Gabriela Bombonica Dogaru. 2024 "Obesity Control and Nutraceuticals in the Aid of Brain Plasticity in Multiple Sclerosis Patients" Preprints. https://doi.org/10.20944/preprints202407.1943.v1
Abstract
Multiple sclerosis (MS) is an immune-mediated disease characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Brain plasticity, the brain's ability to adapt its structure and function, plays a crucial role in mitigating MS's impact. This paper explores the potential benefits of lifestyle changes and nutraceuticals on brain plasticity in MS patients. Lifestyle modifications, including physical activity and dietary adjustments, can enhance brain plasticity by upregulating neurotrophic factors, promoting synaptogenesis, and reducing oxidative stress. Nutraceuticals, such as vitamin D, omega-3 fatty acids, and antioxidants like alpha-lipoic acid, have shown promise in supporting brain health through anti-inflammatory and neuroprotective mechanisms. Regular physical activity has been linked to increased levels of brain-derived neurotrophic factor (BDNF) and improved cognitive function. Dietary interventions, including caloric restriction and the intake of polyphenols, can also positively influence brain plasticity. Integrating these lifestyle changes and nutraceuticals into the management of MS could provide a complementary approach to traditional therapies, potentially improving neurological outcomes and enhancing the quality of life for MS patients.
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
